Drug-Addiction-Treatment-Act-of-2000 (DATA)

The summary for the Drug-Addiction-Treatment-Act-of-2000 (DATA) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Drug-Addiction-Treatment-Act-of-2000 (DATA)
	CFDA Number:	93.243
	CFDA Description:	Substance Abuse and Mental Health Services_Projects of Regional and National Significance
	Federal Agency Name:	Center for Substance Abuse Treatment
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	TI-04-005
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	Mar 25, 2004
	Creation Date:	Jul 02, 2004
	Original Closing Date for Applications:	Jun 02, 2004
	Current Closing Date for Applications:	Information not provided
	Archive Date:	Jul 02, 2004
	Expected Number of Awards:	1
	Estimated Total Program Funding:	$500,000
	Federal Grant Award Ceiling:	$500,000
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Eligibility is limited to the national professional medical organizations authorized by DATA to carry out training. These are the American Society of Addiction Medicine, the American Academy of Addiction Psychiatry, the American Medical Association, the American Osteopathic Association, and the American Psychiatric Association. While any of these entities may apply individually, SAMHSA encourages a consortium comprised of all or several eligible organizations to apply. If a consortium is formed for this purpose, a single organization in the consortium must be the legal applicant, the recipient of the award, and the entity legally responsible for satisfying the grant requirements. If a consortium submits an application, the application must include a written agreement outlining the roles and responsibilities of each participating national professional medical organization. This agreement must be signed by an authorized official of each member of the consortium and attached to the application as a new Appendix 4, ?Roles and Responsibilities of Participating National Professional Medical Organizations.? These eligibility criteria supersede the criteria specified in Section III-1 of SAMHSA's Standard Grant INF-04 PA (MOD).
Grant Description: The purpose of the DATA Physician Clinical Support System cooperative agreement is to develop a coordinated, clinical support program for physicians who are treating addicted patients with buprenorphine products. The target participants for the clinical support system are primary care physicians, pain specialists, psychiatrists and other non-addiction medical practitioners, who are often reluctant to treat addicted patients and are not as familiar with opioid addiction treatment as addictions specialists are. However, addictions specialists will also be encouraged to participate in the DATA Physician Clinical Support System or to serve as mentors. Applicants are expected to develop a coherent, well-designed program to assist physicians in developing the skills and confidence to treat addicted patients, thereby reducing resistance and barriers to the availability of treatment. By enlisting the assistance of professional medical groups and other organizations, the grantee will offer physicians the information and consultation they need to provide safe and effective buprenorphine treatment.
Link to Full Grant Announcement: Notice of Funding Availability: Drug-Addiction-Treatment-Act-of-2000 (DATA) Physician Clinical Support System
http://www.samhsa.gov/grants/2004/nofa/ti04005nofa_DATA.htm
Grant Announcement Contact: Hylton, Raymond, SAMHSA/CSAT, Division of Pharmacologic Therapies, Phone 301-443-6502, Email rhylton@samhsa.gov rhylton@samhsa.gov Hylton, Raymond
Similar Government Grants: • Projects to Deliver Peer-to-Peer Recovery Support Service; • Program Supplement to the Primary and Behavioral Health Care Integration Grants for Health Informati...; • Screening, Brief Intervention, and Referral to Treatment with a Trauma Module; • FY 2011 Supplements for Rapid HIV Testing; • Grants to Expand Care Coordination through the Use of Health Information Technology in Targeted Area...; • Grants to Expand Substance Abuse Treatment Capacity in Targeted Areas of Need; • State Adolescent Substance Abuse Treatment Coordination; • Circles of Care III: Tribal Infrastructure Grants for Transforming Behavioral Health Service Systems...; • Substance Abuse (SA), HIV, & Hepatitis Prevention for Minority Populations and Minority Reentry ...; • Family and Juvenile Treatment Drug Courts